Arwel Jones is a Mid-Career Researcher within the Department of Respiratory Research@Alfred of the School of Translational Medicine.

Arwel is best known for his research into the mechanisms and interventions for respiratory infections and lung disease, including randomised controlled trials on the effects of exercise on the immune system or lung disease and systematic reviews to evaluate existing treatments for lung disease.

He has made an impact in three distinct, but strongly linked areas, which are:

• exercise treatments to reduce hospitalisations in COPD;

• reducing physical inactivity in chronic lung disease;

• prevention of respiratory infections in endurance athletes.

Arwel's work has been recognised through funding from lung charities and the Australian Governement, conference awards from international respiratory societies and publications in leading respiratory and exercise science journals.

Arwel's current research includes projects in the following areas:

• Targeted non-drug approaches in people with chronic lung disease, frequent chest infections and systemic inflammation

• Access to pulmonary rehabilitation in people with COPD 

• Immune responses to booster COVID-19 vaccinations in COPD or Interstitial Lung Disease

• Exercise and influenza or COVID-19 vaccination in COPD

• Anti-viral and anti-inflammatory mechanisms of exercise in COPD

• Oral corticosteroids in asthma and COPD

Alongside conducting research, Arwel has a keen interest in building capacity for community involvement in research and synthesing evidence for clinical practice guidelines as a methodologist. 

Internal positions:

• Deputy Chair of the School of Translational Medicine Community and Researcher Engagement (CaRE) program
• Breathing Easier Together Respiratory Research@Alfred Community Advisory Group
• Community Engagement Coordinator for the School of Translational Medicine Allied Health Translational Research Network